beta-Thalassemia.
Origa R.
Genet Med. 2017 Jun;19(6):609-619. doi: 10.1038/gim.2016.173. Epub 2016 Nov 3.
Thalassemia, a human blood disorder.
Shafique F, Ali S, Almansouri T, Van Eeden F, Shafi N, Khalid M, Khawaja S, Andleeb S, Hassan MU.
Braz J Biol. 2021 Sep 3;83:e246062. doi: 10.1590/1519-6984.246062. eCollection 2021.
Homozygous mild beta-thalassaemia promoter transversion -71 C>T HBB:c.-121 C>T.
Hassan SM, Alrawas A, Al Khanbashi L, Wali Y.
BMJ Case Rep. 2023 Apr 4;16(4):e254416. doi: 10.1136/bcr-2022-254416.
Thalassaemia intermedia.
Wainscoat JS, Thein SL, Weatherall DJ.
Blood Rev. 1987 Dec;1(4):273-9. doi: 10.1016/0268-960x(87)90029-4.
Beta-thalassaemia.
Thein SL.
Baillieres Clin Haematol. 1998 Mar;11(1):91-126. doi: 10.1016/s0950-3536(98)80071-1.
Advances in screening of thalassaemia.
Gao J, Liu W.
Clin Chim Acta. 2022 Sep 1;534:176-184. doi: 10.1016/j.cca.2022.08.001. Epub 2022 Aug 3.
Splenectomy for people with thalassaemia major or intermedia.
Sharma A, Easow Mathew M, Puri L.
Cochrane Database Syst Rev. 2019 Sep 17;9(9):CD010517. doi: 10.1002/14651858.CD010517.pub3.
The Clinical Phenotypes of Alpha Thalassemia.
Lal A, Vichinsky E.
Hematol Oncol Clin North Am. 2023 Apr;37(2):327-339. doi: 10.1016/j.hoc.2022.12.004.
Promoter mutations producing mild beta-thalassaemia in the Italian population.
Meloni A, Rosatelli MC, Faà V, Sardu R, Saba L, Murru S, Sciarratta GV, Baldi M, Tannoia N, Vitucci A, et al.
Br J Haematol. 1992 Feb;80(2):222-6. doi: 10.1111/j.1365-2141.1992.tb08904.x.
Haemoglobinopathies in southeast Asia.
Fucharoen S, Winichagoon P.
Indian J Med Res. 2011 Oct;134(4):498-506.
